Drugs Made in America Acquisition Corp. (DMAAU)
Market Open
26 Oct, 05:58 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
10. 90
-0.21
-1.8902%
$
264.01M Market Cap
- Div Yield
2,569 Volume
$ 11.11
Previous Close Investors:
Want to track DMAAU and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Drugs Made in America Acquisition Corp. (DMAAU) Statistics
Valuation metrics
Market Cap 264.01M
Enterprise value 264.94M
Trailing P/E (ttm) 55.4
Forward P/E -
PEG ratio -0.55
Price/Sales (ttm) -
Price/Book (mrq) 1.59
Enterprise Value/Revenue -
Enterprise Value/EBITDA -100.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 263
Average volume (90 days) 56
Price summary
52-Week low 10.3
52-Week high 12.5
Beta -
50-Day moving average 10.95
200-Day moving average 10.82
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets 0.04%
Return on equity 0.03%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 0.3
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 0.02%
Book value per share (mrq) 6.86
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
